Test for Breast Cancer Treatment: Essential Screenings and Diagnostic Procedures
Breast cancer stage treatment starts with a thorough assessment of the diagnosis, stage, and features of the cancer. Timely and accurate testing is essential for directing treatment, predicting results, and tracking progress.
There are numerous tests that are necessary for identifying breast cancer, tracking its progress, and evaluating the efficacy of treatments both during and after therapy. This guide will explore the various tests which an oncologist in Siliguri may recommend at any stage of the cancer. With the use of these tests, medical experts can decide which treatments such as surgery, chemotherapy, radiation, and targeted therapies are most appropriate.
Imaging and biopsy procedures are usually the first steps in the diagnosis of breast cancer. These diagnostic procedures assist in identifying the type and degree of the cancer as well as confirming whether the suspected tissues are malignant or not. Key tests for the diagnosis of breast cancer are listed below:
One of the most used diagnostic procedures for identifying breast cancer is mammography. An X-ray of the breast tissue can reveal anomalies such as calcifications, tumors, or other changes. In most cases, mammograms can identify cancers that are too small to be felt during a physical examination years before they grow large enough to cause symptoms.
Digital mammograms also have grown in popularity in addition to traditional mammograms because they offer sharper and more detailed images that make it simpler to spot the areas consisting of the cancerous cells. Along with screening, mammograms can also be used to investigate the suspicious findings from other tests.
High-frequency sound waves are used in ultrasound imaging, also known as ultrasonography to create images of the breast's interior anatomy. It is frequently used to further assess suspected areas in combination with mammography.
If a lump is discovered, an ultrasound can assist in distinguishing between a fluid-filled cyst, which is usually benign, and a solid mass, which may be malignant. Biopsy operations can also be guided by ultrasonography.
Another important test for determining whether the abnormal tissue is malignant is a biopsy. The oncologist in Siliguri might recommend a variety of biopsy procedures such as:
Planning the best option for breast cancer treatment in Siliguri is ensured by the information a biopsy offers on the type, grade, and hormone receptor status (such as estrogen or progesterone receptors) of the cancer.
A non-invasive imaging procedure called magnetic resonance imaging (MRI) produces finely detailed images of the breast by using radio waves and powerful magnets. Women who are at high risk for breast cancer or who have dense breast tissue, which can make mammograms difficult to interpret are usually the ones who get an MRI.
In addition to detecting small cancerous regions that may not be prominent on other imaging tests, MRI can assist in determining the degree of cancer spread. In order to confirm that the tumor has been totally eliminated, it is also used to assess the outcomes of breast-conserving surgery.
A CT scan offers detailed cross-sectional pictures of the body and is used to assess whether breast cancer has spread to distant organs like the liver, lungs, bones, or lymph nodes.
The cancer surgeon in Siliguri can stage the disease and choose the best course of treatment by using a CT scan to identify regions where the cancer has spread. Patients with more advanced breast cancer or those who experience symptoms that point to metastases are often the ones who undergo this test.
By identifying the regions of high metabolic activity, which is a characteristic of cancer cells, a PET scan is a sort of imaging test that helps in the identification of malignant tissues.
PET CT scans can be used to determine whether distant organs or lymph nodes have been affected by breast cancer. This test can occasionally be used in conjunction with a CT scan (PET/CT) to provide more precise information regarding the location and the amount of metastases.
In order to determine the risk of inherited breast cancer, genetic testing is essential. Finding genetic abnormalities, like those in BRCA1 or BRCA2 can help predict the risk of getting cancer and help in determining effective treatment choices.
In addition to that, more thorough screening and preventive interventions, like prophylactic surgery or targeted medications such as PARP inhibitors may be beneficial for those with BRCA mutations.
Determining the stage of the cancer after a diagnosis is crucial for treatment planning. Staging tests determine whether cancer has progressed to distant organs and to what degree. Additionally, these tests assist cancer specialists in tracking the efficacy of the treatment both during and after sessions. Key staging and monitoring tests for determining the stage of breast cancer are listed below:
As was already noted, breast cancer treatment staging and the spread of the cancer are frequently determined by CT and PET scans. The PET scan identifies regions of increased metabolic activity linked to cancer cells, whereas the CT scan offers detailed views of the chest, abdomen, and pelvis. These scans are useful for assessing whether cancer has progressed to bones, lymph nodes, or other organs.
A specialist test called a bone scan is done to determine whether breast cancer has migrated to the bones or not. In most cases, advanced breast cancer has bone metastases, and a bone scan can help detect abnormal bone growth that might be a sign of metastatic cancer. When patients have symptoms like unexplained bone pain or tenderness, this test is especially helpful. Potential metastatic locations can be highlighted during the scan by injecting a radioactive tracer into a vein, which is often absorbed by the bone regions showcasing abnormal activity.
To look for signs of lung metastasis where cancer cells may spread to the lungs, a chest X-ray can be recommended. The chest cavity and lungs can be clearly seen on an X-ray, which can also identify any anomalies such as fluid build-up or new growths. A chest X-ray may be performed to determine whether cancer has progressed to the lungs if a patient has symptoms such a chronic cough, trouble breathing, or chest pain.
Since the lymph nodes are one of the first places where breast cancer metastasizes, lymph node biopsies are essential for assessing whether the cancer has spread there or not. To find the first lymph node that drains lymph from the breast, a sentinel lymph node biopsy is often carried out. It is unlikely that the cancer has spread to additional lymph nodes if the sentinel node is cancer-free. Other nodes might be examined or removed, if cancer cells are discovered in the sentinel node.
A biopsy of the lymph nodes may occasionally be guided by ultrasound, particularly if the lymph nodes are swollen. By ensuring that the appropriate tissue is collected for testing, this procedure makes it easier to determine whether cancer has progressed to the lymphatic system.
The CTC test identifies cancer cells that are present in the blood. This test is used to evaluate the efficacy of treatment or track the occurrence of breast cancer recurrence. Even when imaging tests reveal no outward symptoms, the presence of CTCs in the blood may be a clue that cancer is spreading. Although the CTC test is still in its infancy and is only used in research settings, it has the potential to be used for early metastatic identification.
These are effective tests to determine whether hormone receptors (progesterone and estrogen) are present on the tumor which are crucial for some forms of breast cancer. Cancer is more likely to react to hormone therapy, such as Tamoxifen or aromatase inhibitors, if the cancer cells have these receptors. For patients with hormone receptor-positive breast cancer, these tests aid in choosing the most effective treatment plan.
Some breast cancer cells include a protein called HER2 on their surface that encourages the proliferation of cancer cells. By checking for HER2, oncologists can decide if a patient will benefit from targeted treatments that specifically target the HER2 protein such as Trastuzumab. These treatment options may be more successful in limiting tumor growth and reducing the likelihood of recurrence if the cancer cells test positive for HER2 overexpression.
From the first diagnosis to continuing monitoring and staging, testing is a crucial component of undergoing breast cancer treatment in Siliguri . Oncologists can accurately identify the malignancy, choose the appropriate course of treatment, and monitor patient progress throughout the treatment plan because of the range of diagnostic and staging tests available.
These tests' role in early diagnosis and ongoing monitoring are essential for enhancing patient outcomes and delivering focused and efficient care. Patients who get the benefits and role of these tests will feel more equipped to actively undergo their treatment. To receive more details about the best treatment for your condition, you can book an appointment with Dr. Sudip Haldar .
Copyrights © 2025, Dr. Sudip Haldar.
